Categories Consumer, U.S. Markets News

A quick look at analyst recommendations on Tesla (TSLA) stock

Though analysts, in general, remain skeptic about the health of Tesla Motors (TSLA), the recent operational improvements in production and the stock rally have given at least some of them a reason to reconsider their hypothesis.

The stock has gained 26% since reporting strong third-quarter results on October 24, compared to just 10% by rival Ford (F) and 17% by General Motors (GM). The S&P 500 index has increased just 1.5% during this period.

analyst recommendations on tesla tsla stock

The stock currently has a 12-month average price target of $331.70. This price target is at an 8% discount from Thursday’s close of $363.06, suggesting a majority of the analysts expect to see a dip in stock price. The stock currently has an average consensus rating of HOLD.

Alexander Haissl of Berenberg Bank holds the highest price target of  $500 on the stock. Reiterating a BUY rating on the stock, Haissl said he sees no real competition to Tesla. He feels it is up to all three major US automakers to prove their mettle in the electric vehicle industry, though Tesla holds an edge.

Notably, Haissl recommends SELL rating on both GM and Ford.

David Tamberrino of Goldman Sachs is the biggest Tesla bear at the moment. He has a SELL rating on the stock with a price target of $200.

Meanwhile, on Friday, Philippe Houchois of Jefferies upgraded the stock from HOLD to BUY and increased price target from $360 to $450, citing Tesla’s improving balance sheet and industry outperformance.

‘Model 3 killers’ coming from all sides, yet the Tesla EV may emerge unscathed

He stated in a note, “In short, in the year ahead we think only Tesla will avoid a volume zero-sum-game or negative margin trade-off in EVs.”

On the other hand, UBS Group last week reiterated SELL rating on the stock with a price target of $230.

Clearly, the market is divided at the moment on the expectations for Tesla’s future.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to

Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights

Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per

BA Earnings: Highlights of Boeing’s Q1 2024 financial results

The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top